Companies / Legend Biotech Corp

Legend Biotech Corp

Nasdaq: LEGNCIK 1801198SOMERSET, NJ

Ownership

369.9M shares outstanding
13.1%10%+ / strategic
Ownership
10%+ / strategic13.06%48,294,445
Institutions18.13%67,042,063
Public float68.82%254,549,861

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 12

View all →
Insider% of sharesShares
Huang YingCEOChief Executive Officer · Director
Kung GarethDirector
Mao LiDirector
Meng RobinDirector
Santos Carlos EChief Financial Officer

Institutional holders 212

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
AllianceBernstein L.P.
13F manager
ExitADR$-32.98M-1.5M
-100.00%
0
medium
Q1 2026
as of
Deerfield Management Company, L.P.
13F manager
AddADR$31.76M+1.8M
+29.60%
7,687,638
2.08% of shares
medium
Q1 2026
as of
Two Sigma Investments, LP
13F manager
AddADR$24.68M+1.4M
+259.34%
1,890,396
0.51% of shares
medium
Q3 2023
as of
Barclays PLC
13F manager
AddADR$13.26M+197K
+235.69%
281,094
0.08% of shares
medium
Q2 2026
as of
BlackRock, Inc.
13F manager
AddADR$12.99M+450K
+10.51%
4,726,534
1.28% of shares
medium
Q1 2023
as of
Barclays PLC
13F manager
TrimADR$-11.99M-249K
-52.67%
223,538
0.06% of shares
medium
Q2 2023
as of
Barclays PLC
13F manager
TrimADR$-9.65M-140K
-62.54%
83,737
0.02% of shares
medium
Q1 2026
as of
Marshall Wace, LLP
13F manager
TrimADR$-8.48M-469K
-62.02%
287,123
0.08% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Fmr LLCPassive13G/A48,294,445

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LEGNADREquity52490G102BBG00TTGH5W4